Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft Survival
Even though the cornea is regarded as an immune-privileged tissue, transplantation always comes with the risk of rejection due to mismatches between donor and recipient. It is common sense that an alternative to corticosteroids as the current gold standard for treatment of corneal transplantation is...
Main Authors: | Alfrun Schönberg, Matthias Hamdorf, Felix Bock |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/5/1280 |
Similar Items
-
Matured Tolerogenic Dendritic Cells Effectively Inhibit Autoantigen Specific CD4+ T Cells in a Murine Arthritis Model
by: Manon A. A. Jansen, et al.
Published: (2019-08-01) -
Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid Arthritis
by: Willem van Eden, et al.
Published: (2019-02-01) -
Systemic immunomodulatory strategies in high-risk corneal transplantation
by: Tulio B Abud, et al.
Published: (2017-01-01) -
Multiquadrant Subtenon Triamcinolone Injection for Acute Corneal Graft Rejection: A Case Report
by: Sunali Goyal, et al.
Published: (2017-05-01) -
Role of Endogenous Regulators of Hem- And Lymphangiogenesis in Corneal Transplantation
by: Thomas Clahsen, et al.
Published: (2020-02-01)